TRINCE
Trince is advancing cell-based science and therapeutics by facilitating the delivery of molecules into cells, both in vitro and ex vivo.
TRINCE
Industry:
Biopharma Biotechnology Genetics
Founded:
2014-01-01
Address:
Asse, Vlaams-Brabant, Belgium
Country:
Belgium
Website Url:
http://www.trince.be
Total Employee:
51+
Status:
Active
Total Funding:
4 M EUR
Technology used in webpage:
SPF Gandi.net DNS Gandi
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Current Employees Featured
Founder
Investors List
Novalis Biotechnology Incubation
Novalis Biotechnology Incubation investment in Seed Round - Trince
Qbic Fund
Qbic Fund investment in Seed Round - Trince
Official Site Inspections
http://www.trince.be
- Host name: 188.208.36.65.static.hosted.by.combell-ops.net
- IP address: 188.208.36.65
- Location: Belgium
- Latitude: 50.8509
- Longitude: 4.3447
- Timezone: Europe/Brussels
